The CCA HIV/AIDS Initiative is working with CCA members and partners to increase access to funding opportunities and treatment options for HIV/AIDS private sector initiatives.
- The World Bank Multi-Country AIDS Program (MAP Program)
The World Bank has allocated $1.5 billion for a grant program focused on HIV/AIDS. The funds, channeled through each country's National AIDS Commission, are divided between the public sector and civil society, which includes corporations as well as NGOs. Thus far, 28 African countries and three regional programs have received US$1,088.2 million from the MAP and projects are currently being prepared in another ten countries.
- USAID & the President's Emergency Plan for AIDS Relief (PEPFAR)
In the 2003 State of the Union address, President Bush announced his Emergency Plan for AIDS Relief (PEPFAR). It provides $15 billion, including nearly $10 billion in new funding, to fight the HIV/AIDS pandemic over the next 5 years. One billion of the new funding, over 5 years, is a pledge to the Global Fund to Fight AIDS, Tuberculosis, and Malaria.
- Centers for Disease Control and Prevention (CDC)
CDC's Global AIDS Program (GAP) works collaboratively with other U.S. government agencies, including the U.S. Agency for International Development (USAID); international health and economic organizations such as WHO, UNAIDS, the United Nations Children's Fund, and the World Bank; nongovernmental organizations; and host country governments to achieve the PEPFAR goals.
- The Global Fund to Fight HIV/AIDS, Malaria and Tuberculosis
The Global Fund to Fight AIDS, Tuberculosis and Malaria was created to dramatically increase resources to fight three of the world's most devastating diseases and to direct those resources to areas of greatest need.
As a partnership between governments, civil society, the private sector and affected communities, the Global Fund represents an innovative approach to international health financing.
Access to Treatment for Private Sector Programs
- AccessToTreatment.org
AccessToTreatment.org represents the cooperative effort of five companies in the healthcare field to provide institutions and their patients in Least Developed Countries access to the medical products provided under this cooperation. AccessToTreatment.org currently runs four donation (products are free) and two access (products are sold at no-profit) programs.
- AXIOS: Prevention Mother to Child Transmission
Through the PMPCT Donations program, eligible organizations with comprehensive PMTCT prevention can receive -- at no charge -- Abbott's Determine® HIV 1/2 rapid tests and VIRAMUNE® (nevirapine), an antiretroviral treatment discovered and developed by Boehringer Ingelheim. Both companies are working with Axios International, an organization for improvement of health care in developing countries, to provide a simple application process for PMTCT programs.
